| First Author | Keiffer TR | Year | 2014 |
| Journal | J Biol Chem | Volume | 289 |
| Issue | 11 | Pages | 7580-8 |
| PubMed ID | 24474695 | Mgi Jnum | J:213004 |
| Mgi Id | MGI:5582679 | Doi | 10.1074/jbc.M113.546309 |
| Citation | Keiffer TR, et al. (2014) Meprin metalloproteases inactivate interleukin 6. J Biol Chem 289(11):7580-8 |
| abstractText | Meprins have been implicated in the pathogenesis of several inflammatory diseases, including inflammatory bowel disease, in which the cytokine IL-6 is a prominent effector molecule. Because IL-6 levels are elevated markedly in meprin alpha and alpha/beta knockout mice in an experimental model of inflammatory bowel disease, the interaction between meprins and IL-6 was studied. The results demonstrate that rodent and human meprin A and B cleave IL-6 to a smaller product and, subsequently, are capable of extensive degradation of the cytokine. Analysis of the limited degradation product formed by meprin A indicated that three to five amino acids are removed from the C terminus of the cytokine. Meprin A and meprin B cleaved IL-6 with micromolar affinities (Km of 4.7 and 12.0 muM, respectively) and with high efficiencies (kcat/Km of 0.2 and 2.5 (M(-1)/s(-1)) x 10(6), respectively). These efficiency constants are among the highest for known meprin substrates. Madin-Darby canine kidney cells transiently transfected with meprin alpha or meprin beta constructs also cleave exogenous IL-6. Both human and murine IL-6 cleaved by meprin A or B are inactivated, as demonstrated by their decreased capability to stimulate proliferation of B9 cells. These results are consistent with the proposition that one function of meprin metalloproteases is to modulate inflammation by inactivating IL-6. |
